* . *
  • About
  • Advertise
  • Privacy & Policy
  • Contact
Tuesday, September 16, 2025
Earth-News
  • Home
  • Business
  • Entertainment
    The Emmys are back: Viewership soars to highest numbers in 4 years – yahoo.com

    The Emmys Return with a Bang: Viewership Hits a 4-Year High

    From Spinal Tap II to Ed Sheeran : your complete entertainment guide to the week ahead – The Guardian

    Fall’s Hottest Ski Films Are Going on Tour—Here’s the List – yahoo.com

    Experience the Thrill: Fall’s Hottest Ski Films Hit the Road-Don’t Miss the Tour!

    Ryan Reynolds reveals he called a journalist who said mean things about John Candy – yahoo.com

    Ryan Reynolds Reveals the Moment He Stood Up to a Journalist Who Insulted John Candy

    Entertainment Community Fund Launches Program Supporting Entrepreneurs – Playbill

    Entertainment Community Fund Unveils Exciting New Program to Empower Entrepreneurs

    Behind the turntables: DJ Johnny Kage’s story of perseverance – yahoo.com

    Behind the Turntables: DJ Johnny Kage’s Inspiring Journey of Perseverance

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    Will New Big Technology Engagements Reshape Innodata’s Growth Path? – Yahoo Finance

    Could New Major Tech Partnerships Propel Innodata to Unprecedented Growth?

    Unlocking AI Success: How People, Process, and Technology Form the Ultimate Triangle

    Billion-dollar coffins? New technology could make oceans transparent and Aukus submarines vulnerable – The Guardian

    Billion-Dollar Coffins? How New Technology Could Make Oceans Transparent and Expose Submarines

    What if artificial intelligence is just a “normal” technology? – The Economist

    What if artificial intelligence is just a “normal” technology? – The Economist

    Lincoln Trail College Receives $100,000 Grant from Marathon Petroleum Corporation for Technology Center – wwbl.com

    Lincoln Trail College Lands $100,000 Grant from Marathon Petroleum to Elevate Technology Center

    Aston Martin to integrate Pirelli’s cyber tyre technology in future models – Just Auto

    Aston Martin to Revolutionize Future Models with Pirelli’s Cutting-Edge Cyber Tyre Technology

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
  • Home
  • Business
  • Entertainment
    The Emmys are back: Viewership soars to highest numbers in 4 years – yahoo.com

    The Emmys Return with a Bang: Viewership Hits a 4-Year High

    From Spinal Tap II to Ed Sheeran : your complete entertainment guide to the week ahead – The Guardian

    Fall’s Hottest Ski Films Are Going on Tour—Here’s the List – yahoo.com

    Experience the Thrill: Fall’s Hottest Ski Films Hit the Road-Don’t Miss the Tour!

    Ryan Reynolds reveals he called a journalist who said mean things about John Candy – yahoo.com

    Ryan Reynolds Reveals the Moment He Stood Up to a Journalist Who Insulted John Candy

    Entertainment Community Fund Launches Program Supporting Entrepreneurs – Playbill

    Entertainment Community Fund Unveils Exciting New Program to Empower Entrepreneurs

    Behind the turntables: DJ Johnny Kage’s story of perseverance – yahoo.com

    Behind the Turntables: DJ Johnny Kage’s Inspiring Journey of Perseverance

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    Will New Big Technology Engagements Reshape Innodata’s Growth Path? – Yahoo Finance

    Could New Major Tech Partnerships Propel Innodata to Unprecedented Growth?

    Unlocking AI Success: How People, Process, and Technology Form the Ultimate Triangle

    Billion-dollar coffins? New technology could make oceans transparent and Aukus submarines vulnerable – The Guardian

    Billion-Dollar Coffins? How New Technology Could Make Oceans Transparent and Expose Submarines

    What if artificial intelligence is just a “normal” technology? – The Economist

    What if artificial intelligence is just a “normal” technology? – The Economist

    Lincoln Trail College Receives $100,000 Grant from Marathon Petroleum Corporation for Technology Center – wwbl.com

    Lincoln Trail College Lands $100,000 Grant from Marathon Petroleum to Elevate Technology Center

    Aston Martin to integrate Pirelli’s cyber tyre technology in future models – Just Auto

    Aston Martin to Revolutionize Future Models with Pirelli’s Cutting-Edge Cyber Tyre Technology

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
Earth-News
No Result
View All Result
Home Health

Esketamine Tops Quetiapine in Treatment-Resistant Depression

October 5, 2023
in Health
Esketamine Tops Quetiapine in Treatment-Resistant Depression
Share on FacebookShare on Twitter

Esketamine nasal spray (Spravato) led to better remission rates compared with extended-release quetiapine (Seroquel XR) in patients with treatment-resistant depression when used in combination with ongoing treatment, the randomized phase IIIb ESCAPE-TRD trial showed.

Among patients who were taking a selective serotonin reuptake inhibitor (SSRI) or a serotonin-norepinephrine reuptake inhibitor (SNRI), those who received adjunctive intranasal esketamine had better rates of remission at 8 weeks compared with adjunctive quetiapine (27.1% vs 17.6%; adjusted OR 1.74, 95% CI 1.20-2.52) based on the Montgomery-Åsberg Depression Rating Scale (MADRS), reported Andreas Reif, MD, of the University Hospital Frankfurt-Goethe University in Germany, and co-authors.

In addition, 21.7% of patients in the esketamine group had no relapse through 32 weeks after remission at week 8 versus 14.1% of those in the quetiapine group (aOR 1.72, 95% CI 1.15-2.57), they noted in the New England Journal of Medicine.

“Approximately one-third of people who suffer from major depressive disorder do not respond to treatment and are considered to have treatment-resistant depression,” Reif told MedPage Today in an email. “Research into treatments for treatment-resistant depression is essential, to help break the cycle of treatment failure and to combat the devastating impact that treatment-resistant depression has on people living with the condition.”

“Remission is the ultimate goal for the acute phase of antidepressive treatment, followed by preventing relapse once remission is achieved,” he noted. “The primary and key secondary endpoints represent major milestones in the course of treating depression for patients and clinicians and are even more significant and difficult to achieve in a treatment-resistant depression participant population.”

He noted that the rates of remission and relapse were in line with expectations based on previous studies, but that the continued increase in these rates all the way up to week 32 was unexpected. “This consolidates the importance of esketamine nasal spray as a long-term therapeutic option for adults with treatment-resistant depression,” he said.

“Given the different methods of administration of the two medicines … conducting the study open-label avoided the need to use a placebo, which reduced the burden on study patients in the quetiapine extended-release arm in terms of less frequent visits to treatment [centers],” he added.

In an accompanying editorial, Rupert McShane, MD, of the Oxford Health NHS Foundation Trust and the University of Oxford in England, noted that the trial provided positive progress in research on the use of esketamine nasal spray.

“Real-world experience with esketamine nasal spray has also been reassuring,” he wrote. “Cystitis and cognitive impairment remain theoretical, rather than actual, risks. Similarly, overuse is prevented because the nasal spray has to be administered in the clinic, which also enhances the opportunity for regular review.”

Despite the concerns around the use of esketamine in clinical settings, McShane said that this trial “supports the radical and disruptive idea that esketamine nasal spray has a place early in the sequence of antidepressant treatment.”

For this study, patients were recruited from August 2020 through November 2021 at 171 sites — including hospitals, inpatient and outpatient clinics, and research centers — across 24 countries.

Reif and colleagues randomized 336 patients to receive a flexible dose of esketamine nasal spray (median age 45, 67% women) and 340 patients to extended-release quetiapine (median age 47, 65.3% women) in combination with an SSRI or SNRI. The primary endpoint was remission at 8 weeks defined by a score of 10 or less on the MADRS (scores range from 0 to 60, with higher scores indicating more severe depression).

All enrolled patients were included in the analysis, with patients who discontinued treatment being counted as having an unfavorable outcome.

As for other secondary endpoints, patients in the esketamine group were more likely to be in remission at 32 weeks compared with those in the quetiapine group (49.1% vs 32.9%; OR 1.96, 95% CI 1.44-2.68). Similarly, 65.5% of patients in the esketamine group showed a treatment response at 32 weeks compared with 47.1% of those in the quetiapine group (OR 2.13, 95% CI 1.57-2.91).

Adverse events occurred in most patients in both the esketamine group (91.9%) and the quetiapine group (78%), but serious adverse events were far less common (5.7% vs 5.1%, respectively). The researchers noted that two patients in the esketamine group had serious adverse events — acute coronary syndrome at 21 weeks and dizziness at 2 weeks — that were considered to be related to the treatment. There were no serious adverse events considered to be related to treatment in the quetiapine group.

author['full_name']

Michael DePeau-Wilson is a reporter on MedPage Today’s enterprise & investigative team. He covers psychiatry, long covid, and infectious diseases, among other relevant U.S. clinical news. Follow

Disclosures

This study was funded by Janssen EMEA.

Reif reported consulting for Boehringer Ingelheim GmbH, Compass, Janssen Pharmaceuticals, LivaNova USA, Medice, Sage Therapeutics, and Shire.

Co-authors reported multiple relationships with industry.

McShane reported a relationship with Janssen Pharmaceuticals.

Primary Source

New England Journal of Medicine

Source Reference: Reif A, et al “Esketamine nasal spray versus quetiapine for treatment-resistant depression” N Engl J Med 2023; DOI: 10.1056/NEJMoa2304145.

Secondary Source

New England Journal of Medicine

Source Reference: McShane R “Loosening the shackles of depression” N Engl J Med 2023; DOI: 10.1056/NEJMe2309758.

>>> Read full article>>>
Copyright for syndicated content belongs to the linked Source : MedPageToday – https://www.medpagetoday.com/psychiatry/depression/106642

Tags: EsketaminehealthQuetiapine
Previous Post

San Francisco-based OWN Real Estate makes the leap to Keller Williams

Next Post

How Bad Will This Respiratory Virus Season Be? CDC Weighs In.

Antibiotic pollution could accelerate amphibian decline by turning a potential solution into a threat – Phys.org

Antibiotic pollution could accelerate amphibian decline by turning a potential solution into a threat – Phys.org

September 16, 2025
Fiji’s Ants Are Struggling. Scientists Say They’re Part of the Broader ‘Insect Apocalypse’ – Smithsonian Magazine

Fiji’s Ants Are Disappearing: A Stark Sign of the Global Insect Crisis

September 16, 2025

California Leads the Way with a Bipartisan, Science-Backed Ban on Ultra-Processed School Meals

September 16, 2025

Marwa Zaied: Leading the Revolution in Cancer Care and Longevity with Lifestyle Medicine

September 16, 2025
Will New Big Technology Engagements Reshape Innodata’s Growth Path? – Yahoo Finance

Could New Major Tech Partnerships Propel Innodata to Unprecedented Growth?

September 16, 2025
Registration open for fitness programs at Hereford Sports & Wellness – KFDA | NewsChannel 10

Registration open for fitness programs at Hereford Sports & Wellness – KFDA | NewsChannel 10

September 16, 2025
Men’s Freestyle Team Standings At The 2025 Senior World Championship – FloWrestling

Men’s Freestyle Team Standings at the 2025 Senior World Championship Revealed

September 15, 2025
ONEflight Myrtle Beach Classic boosts economy with $15.8M impact – WPDE

ONEflight Myrtle Beach Classic boosts economy with $15.8M impact – WPDE

September 15, 2025
The Emmys are back: Viewership soars to highest numbers in 4 years – yahoo.com

The Emmys Return with a Bang: Viewership Hits a 4-Year High

September 15, 2025
Bridging gap between artificial intelligence, real-world health outcomes – Rice University

Bridging the Divide: How Artificial Intelligence is Transforming Real-World Health Outcomes

September 15, 2025

Categories

Archives

September 2025
MTWTFSS
1234567
891011121314
15161718192021
22232425262728
2930 
« Aug    
Earth-News.info

The Earth News is an independent English-language daily published Website from all around the World News

Browse by Category

  • Business (20,132)
  • Ecology (822)
  • Economy (841)
  • Entertainment (21,719)
  • General (17,059)
  • Health (9,885)
  • Lifestyle (856)
  • News (22,149)
  • People (845)
  • Politics (850)
  • Science (16,052)
  • Sports (21,341)
  • Technology (15,823)
  • World (824)

Recent News

Antibiotic pollution could accelerate amphibian decline by turning a potential solution into a threat – Phys.org

Antibiotic pollution could accelerate amphibian decline by turning a potential solution into a threat – Phys.org

September 16, 2025
Fiji’s Ants Are Struggling. Scientists Say They’re Part of the Broader ‘Insect Apocalypse’ – Smithsonian Magazine

Fiji’s Ants Are Disappearing: A Stark Sign of the Global Insect Crisis

September 16, 2025
  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

Go to mobile version